Alexion is purchased by Covid-19 vaccine developer AstraZeneca for $39 billion
Major Covid-19 vaccine developer AstraZeneca agreed on Saturday to purchase Boston pharmaceutical firm Alexion for $39 billion. © Dan Himbrechts/EPA-EFE/Shutterstock…
Livingston
Major Covid-19 vaccine developer AstraZeneca agreed on Saturday to purchase Boston pharmaceutical firm Alexion for $39 billion. © Dan Himbrechts/EPA-EFE/Shutterstock…
WhatsApp us